Towards a new tuberculosis drug: pyridomycin – nature's isoniazid

Tuberculosis, a global threat to public health, is becoming untreatable due to widespread drug resistance to frontline drugs such as the InhA-inhibitor isoniazid. Historically, by inhibiting highly vulnerable targets, natural products have been an important source of antibiotics including potent ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartkoorn, Ruben C, Sala, Claudia, Neres, João, Pojer, Florence, Magnet, Sophie, Mukherjee, Raju, Uplekar, Swapna, Boy-Röttger, Stefanie, Altmann, Karl-Heinz, Cole, Stewart T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2012
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491834/
https://www.ncbi.nlm.nih.gov/pubmed/22987724
http://dx.doi.org/10.1002/emmm.201201689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491834/
https://www.ncbi.nlm.nih.gov/pubmed/22987724
http://dx.doi.org/10.1002/emmm.201201689

Ejemplares similares